Hair Growth Under Dupilumab in Alopecia Areata Universalis and Atopic Dermatitis
October 2021
in “
Deleted Journal
”
Studysummary This case report details a 46-year-old woman with severe atopic dermatitis and alopecia areata universalis who experienced renewed hair growth and improved skin symptoms after starting dupilumab therapy. Our plain-language summary of this paper — not a Tressless recommendation.
A 46-year-old woman with severe atopic dermatitis and alopecia areata universalis experienced significant hair regrowth on her scalp, face, and lower legs after starting dupilumab therapy. Dupilumab, which blocks the IL-4 receptor α-subunit and reduces Th2 immune response, also alleviated her severe eczema and itching within 14 days, improving her sleep and quality of life without significant side effects. This suggests that patients with severe atopic dermatitis and alopecia areata may benefit from dupilumab treatment.
